when should you take retatrutide How To Use Properly Your First Time how often should you inject

In clinical trials, headaches were typically mild and ranked lower in severity and frequency compared to other metabolic adaptation side effects

Tirzepatide tends to produce greater weight loss on average (20.9% in SURMOUNT-1 versus 14.9% in STEP 1), which may translate to slightly more pronounced menstrual effects

To be avoided in case of chronic liver disease, seizures/epilepsy

Regularly track weight, appetite, hunger patterns, and relevant metabolic markers such as HbA1c

Despite the objective improvements, only 26.7% (Group A) and 14.3% (Group B) rated results "good" or "excellent." This highlights the gap between measurable hair count increases and subjective satisfaction patients often need to see dramatic visual change to feel satisfied, which may require longer treatment or combination approaches

Kang XY, Zhang Y, Song JW, Wang L, Li W, Qi J, Tang BZ